πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

ALMIRALL S.P.A Patents

Full USPTO pharma patent portfolio for ALMIRALL S.P.A β€” grant dates, expiration, and drug cross-links.

Patents
308
Expiring ≀24m
14

Quick answer

ALMIRALL S.P.A has 308 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 14 expire within 24 months β€” use filters for patent-cliff planning.

Page 6 of 7

  1. US 8034826

    Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7977359

    5-lipdxygenase-activating protein (FLAP) inhibitors

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7964615

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptor

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7960383

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7919621

    Tricyclic inhibitors of 5-lipoxygenase

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7906530

    1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7897617

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7893087

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7879874

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7855202

    Imidazopyridine derivatives as A2B adenosine receptor antagonists

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7834037

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7811602

    Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7795274

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7790728

    Pyrazine derivatives useful as adenosine receptor antagonists

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7776879

    Quinuclidine carbamate derivatives and their use as M3 antagonists

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7750023

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7718670

    Quinuclidine amide derivatives

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7662814

    4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7622480

    Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7582676

    2-phenylpyran-4-one derivatives as selective COX-2 inhibitors

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7560471

    Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents

    Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7557212

    Tricyclic derivatives as LTD4 antagonists

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7521551

    Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7511038

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7504398

    Substituted-4-(pyrrolo pyrimidin-6-yl)benzenesulphonamide derivatives

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7491722

    Pyridazin-3(2H)-one derivatives

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7491707

    Synthetic lipid-a-analogs and uses thereof

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7488735

    Quinuclidine amide derivatives

    Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7459453

    Pyridazin-3(2H)-one derivatives as PDE4 inhibitors

    Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7435742

    Quinuclidine derivatives and pharmaceutical compositions containing the same

    Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7405302

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7358260

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7354936

    2-phenylpyran-4-one derivatives

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7312231

    Quinuclidine carbamate derivatives and their use as M3 antagonists

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7253171

    Urea derivatives as integrin Ξ±4 antagonists

    Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7244448

    Liposomal antineoplastic drugs and uses thereof

    Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7214687

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7208501

    Quinuclidine carbamate derivatives and their use as M3 antagonists

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7196098

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7192978

    Pyrrolidinium derivatives

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7189741

    Indolylpiperidine derivatives as antihistaminic and antiallergic agents

    Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7122558

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7109210

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7078412

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7060824

    Pyrrolotriazolopyrimidinone derivatives

    Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7034016

    8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives

    Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6943253

    6-phenylpyrrolopyrimidinedione derivatives

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6928315

    Apparatus for impedance imaging coupled with another modality

    Expires Mon Aug 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does ALMIRALL S.P.A have?

308 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ALMIRALL S.P.A patents expire?

14 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.